- Home
- SHMD vs HOWL Comparison
SHMD vs HOWL Comparison
Compare SHMD & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHMD
- HOWL
- Stock Information
- Founded
- SHMD 1864
- HOWL 2017
- Country
- SHMD Germany
- HOWL United States
- Employees
- SHMD N/A
- HOWL N/A
- Industry
- SHMD
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- SHMD
- HOWL Health Care
- Exchange
- SHMD Nasdaq
- HOWL Nasdaq
- Market Cap
- SHMD 102.1M
- HOWL 64.5M
- IPO Year
- SHMD N/A
- HOWL 2021
- Fundamental
- Price
- SHMD $2.22
- HOWL $1.40
- Analyst Decision
- SHMD
- HOWL Strong Buy
- Analyst Count
- SHMD 0
- HOWL 5
- Target Price
- SHMD N/A
- HOWL $7.20
- AVG Volume (30 Days)
- SHMD 30.8K
- HOWL 151.8K
- Earning Date
- SHMD 01-01-0001
- HOWL 11-06-2025
- Dividend Yield
- SHMD N/A
- HOWL N/A
- EPS Growth
- SHMD N/A
- HOWL N/A
- EPS
- SHMD N/A
- HOWL N/A
- Revenue
- SHMD $85,165,542.00
- HOWL N/A
- Revenue This Year
- SHMD N/A
- HOWL N/A
- Revenue Next Year
- SHMD N/A
- HOWL N/A
- P/E Ratio
- SHMD N/A
- HOWL N/A
- Revenue Growth
- SHMD N/A
- HOWL N/A
- 52 Week Low
- SHMD $1.86
- HOWL $0.60
- 52 Week High
- SHMD $4.40
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- SHMD 37.92
- HOWL 56.16
- Support Level
- SHMD $2.00
- HOWL $1.38
- Resistance Level
- SHMD $2.48
- HOWL $1.49
- Average True Range (ATR)
- SHMD 0.21
- HOWL 0.07
- MACD
- SHMD -0.02
- HOWL 0.00
- Stochastic Oscillator
- SHMD 30.07
- HOWL 55.00
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.